🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of exogeno...
Status
Completed
Location
David Geffen School of Medicine at UCLA
Start Date
2018-12-05
Trial ID
NCT03769116
Treatments Being Tested
This is a multicenter, Phase 2a, randomized, double-blind, placebo-controll...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01
Trial ID
NCT04505358
Intervention aimed at increasing knowledge of the human papillomavirus in h...
Status
Completed
Location
School of Nursing Benemérita Universidad Autonoma de Puebla
Start Date
2021-12-01
Trial ID
NCT06920589
The aim of this study is to evaluate the synergistic anti-tumor effect of C...
Status
Unknown
Location
Jiege Huo
Start Date
2015-06
Trial ID
NCT02510118
Treatments Being Tested
Hyperacusis is the intolerance to sound levels that normally are judged acc...
Status
Completed
Location
Univ. of Maryland - Baltimore
Start Date
2002-07
Trial ID
NCT00890526
The aim of this trial is to find out if a tablet called apixaban can reduce...
Status
Not Yet Recruiting
Location
University of Birmingham
Start Date
2026-03-02
Trial ID
NCT07160686
The primary aim of the trial is to compare the influence of MICARDIS® (telm...
Status
Completed
Location
Multiple Locations
Start Date
2000-05
Trial ID
NCT02200653
The study will evaluate whether an experimental medical device that emits a...
Status
Unknown
Location
Multiple Locations
Start Date
2019-08-01
Trial ID
NCT04000867
Treatments Being Tested
SRT2104 is a potent small molecule activator of SIRT1 that has been found t...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-12-09
Trial ID
NCT01014117
Excessive daytime sleepiness (EDS) is observed in 30 to 50 % of patients wi...
Status
Completed
Location
UHBordeaux
Start Date
2012-05
Trial ID
NCT02021903
Treatments Being Tested